New York, May 30, 2019: The global stem cells market is expected to grow at an incredible CAGR of 25.5% from 2018 to 2024 and reach a market value of US$ 467 billion by 2024. The emergence of Induced Pluripotent Stem (iPS) cells as an alternative to ESCs (embryonic stem cells), growth of developing markets, and evolution of new stem cell therapies represent promising growth opportunities for leading players in this sector.
Due to the increased funding from Government and Private sector and rising global awareness about stem cell therapies and research are the main factors which are driving this market. A surge in therapeutic research activities funded by governments across the world has immensely propelled the global stem cells market. However, the high cost of stem cell treatment and stringent government regulations against the harvesting of stem cells are expected to restrain the growth of the global stem cells market.
You Can Browse Full Report @: https://www.marketresearchengine.com/reportdetails/global-stem-cells-market-analysis-report
This market research report categorizes the stem cell therapy market into the following segments and sub-segments:
The Global Stem Cell Market this market is segmented on the basis of Mode of Therapy, Therapeutic Applications and Geography.
By Mode of Therapy this market is segmented on the basis of Allogeneic Stem Cell Therapy Market and Autologous Stem Cell Therapy Market. Allogeneic Stem Cell Therapy Market this market is segmented on the basis of CVS Diseases, CNS Diseases, GIT diseases, Eye Diseases, Musculoskeletal Disorders, Metabolic Diseases, Immune System Diseases, Wounds and Injuries and Others. Autologous Stem Cell Therapy Market this market is segmented on the basis of GIT Diseases, Musculoskeletal Disorders, CVS Diseases, CNS Diseases, Wounds and Injuries and Others. By Therapeutic Applications this market is segmented on the basis of Musculoskeletal Disorders, Metabolic Diseases, Immune System Diseases, GIT Diseases, Eye Diseases, CVS Diseases, CNS Diseases, Wounds and Injuries and Others.
By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
This report will definitely help you make well informed decisions related to the stem cell market. The stem cell therapy market includes large number of players that are involved in development of stem cell therapies of the treatment of various diseases. Mesoblast Ltd. (Australia), Aastrom Biosciences, Inc. (U.S.), Celgene Corporation (U.S.), and StemCells, Inc. (U.S.) are the key players involved in the development of stem cell therapies across the globe.
Request Sample Report @: https://www.marketresearchengine.com/reportdetails/global-stem-cells-market-analysis-report
Table of Contents
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
184.108.40.206 Key Data From Secondary Sources
2.1.2 Primary Data
220.127.116.11 Key Data From Primary Sources
18.104.22.168 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Global Stem Cell Therapy Market, By Type
8 Global Stem Cell Therapy Market, By Therapeutic Application
9 Global Stem Cell Therapy Market, By Cell Source
10 Stem Cell Therapy Market, By Region
11 Competitive Landscape
12 Company Profiles
12.1.1 Geographic Benchmarking
12.2 Osiris Therapeutics, Inc.
12.3 Medipost Co., Ltd.
12.4 Anterogen Co., Ltd.
12.5 Pharmicell Co., Ltd.
12.6 Holostem Terapie Avanzate Srl
12.7 JCR Pharmaceuticals Co., Ltd.
12.8 Nuvasive, Inc.
12.9 RTI Surgical, Inc.
Other Related Market Research Reports:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States